Dr. Mona S. Foad, MD

Dr. Foad practices at Cincinnati Dermatology Center in Cincinnati, Ohio.

Dr. Foad's NPI, 1316011661, was assigned on November 20, 2006. Dr. Foad graduated from University Of Cincinnati College Of Medicine in 1998. Dr. Foad holds Ohio license 35-08-1463-F.

Dr. Foad's primary practice is Cincinnati Dermatology Center, at 7730 Montgomery Rd Suite 200 Suite 200, Cincinnati, OH 45236-4284. The practice phone is (513) 984-4800.

Dr. Foad's primary practice is Cincinnati Dermatology Center in Cincinnati, Ohio. The medical group on file is Mona Dermatology. Dmand AI also links Dr. Foad to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Foad practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Foad's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Foad is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Foad's licenses on file in 7 states: Ohio, Florida, Georgia, Arizona, Hawaii, Texas and District of Columbia.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, joint cyst and psoriasis among the conditions Dr. Foad treats.

CMS data shows 5,094 Medicare services from Dr. Foad across 20 procedure codes in 2024, for 867 Medicare patients. Medicare paid $184,399 for them. Every service was in an office.

CMS counts 867 Medicare patients who saw Dr. Foad in 2024. The largest group is 65 to 74, with 511 patients. 71% of them have high cholesterol, and 58% have high blood pressure. Their average risk score is 0.77, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Foad's median patient age at 50, with 70% women.

In 2024, Dr. Foad wrote 435 Medicare Part D claims for 178 patients. 94% of them were for generic drugs. CMS names the drug for 285 of them, across 12 drugs with 11 or more claims each, at $5,305 in total drug cost. In 2023, CMS named 339 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Foad for performance year 2024, reported as part of a group. Dr. Foad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 635 procedures of skin biopsy by Dr. Foad, more than 97% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Foad.

CMS Open Payments shows 882 general payments to Dr. Foad from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Abbvie Inc. paid the most, $155,881.

Dmand AI lists 2 awards for Dr. Foad.

Dr. Foad graduated from University Of Cincinnati College Of Medicine in 1998. Dr. Foad is a member of AAD and ASDS.

Dr. Foad is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.